SELLAS Life Sciences Group, Inc. (SLS) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 111.17M | 75.21M | 49.05M | 29.45M | 31.97M | 16.33M | 24.04M | 12.3M | 21.5M | 3.17M | 5.2M | 15.58M | 26.02M | 17.76M | 22.61M | 28.74M | 17.84M | 23.04M | 28.97M | 34.58M |
| Cash & Short-Term Investments | 107.2M | 71.89M | 44.42M | 25.3M | 28.4M | 13.89M | 21.03M | 9.15M | 18.41M | 2.53M | 3.97M | 13.81M | 23.9M | 17.13M | 21.35M | 26.99M | 14.25M | 21.45M | 26.28M | 29.92M |
| Cash Only | 107.2M | 71.89M | 44.42M | 25.3M | 28.4M | 13.89M | 21.03M | 9.15M | 18.41M | 2.53M | 3.97M | 13.81M | 23.9M | 17.13M | 21.35M | 26.99M | 14.25M | 21.45M | 26.28M | 29.92M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 0 | 0 | 2.24M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 90 | - | - | 60.4 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.97M | 3.32M | 4.63M | 381K | 100K | 100K | 325K | 203K | 189K | 100K | 525K | 100K | 170K | 330K | 147K | 193K | 363K | 27K | 1.95M | 103K |
| Total Non-Current Assets | 3.01M | 3.13M | 2.5M | 2.86M | 2.98M | 3.31M | 2.47M | 2.82M | 2.93M | 3.05M | 2.88M | 2.98M | 3.08M | 3.19M | 3.4M | 3.47M | 3.6M | 3.38M | 8.98M | 9.05M |
| Property, Plant & Equipment | 839K | 963K | 556K | 683K | 806K | 925K | 513K | 633K | 747K | 858K | 592K | 690K | 784K | 874K | 961K | 1.04M | 1.13M | 723K | 767K | 812K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.08x | - | - | 2.28x |
| Goodwill | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.7M | 5.7M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -184K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 255K | 257K | 34K | 261K | 263K | 466K | 43K | 270K | 272K | 275K | 377K | 381K | 384K | 399K | 521K | 514K | 554K | 594K | 597K | 623K |
| Total Assets | 114.18M | 78.34M | 51.55M | 32.3M | 34.96M | 19.43M | 26.5M | 15.12M | 24.43M | 6.22M | 8.09M | 18.57M | 29.1M | 20.94M | 26M | 32.21M | 21.43M | 26.43M | 37.95M | 43.62M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.04x | - | - | 0.05x |
| Asset Growth % | 226.63% | 303.18% | 94.51% | 113.67% | 43.06% | 212.46% | 227.79% | -18.57% | -16.05% | -70.31% | -68.9% | -42.36% | 35.78% | -20.75% | -31.49% | -26.16% | -47.17% | -42.61% | 105.05% | 200.57% |
| Total Current Liabilities | 6.46M | 7.02M | 5.92M | 6M | 6.89M | 9.51M | 10.61M | 12.04M | 14.44M | 13.73M | 11.73M | 13.42M | 15.51M | 15.52M | 12.55M | 12.19M | 10.68M | 4.98M | 5.32M | 4.24M |
| Accounts Payable | 3.63M | 2.95M | 2.31M | 3.34M | 3.76M | 3.5M | 4.55M | 6.33M | 7.41M | 5.64M | 4.34M | 3.73M | 3.1M | 3.36M | 2.13M | 3.34M | 2.84M | 2.14M | 2.54M | 2.28M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.05K | - | - | 1.55K | 169.44 | - | 2.1K |
| Short-Term Debt | 562K | 544K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 198K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.26M | 3.52M | 3.02M | 1.06M | 653K | 1.82M | 1.96M | 1.84M | 1.64M | 1.53M | 214K | 1.19M | 656K | 5.5M | 1.42M | 1.16M | 702K | 1.65M | 281K | 826K |
| Current Ratio | 17.22x | 10.72x | 8.28x | 4.91x | 4.64x | 1.72x | 2.26x | 1.02x | 1.49x | 0.23x | 0.44x | 1.16x | 1.68x | 1.14x | 1.80x | 2.36x | 1.67x | 4.63x | 5.45x | 8.16x |
| Quick Ratio | 17.22x | 10.72x | 8.28x | 4.91x | 4.64x | 1.72x | 2.26x | 1.02x | 1.49x | 0.23x | 0.44x | 1.16x | 1.68x | 1.14x | 1.80x | 2.36x | 1.67x | 4.63x | 5.45x | 8.16x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 309K | 457K | 0 | 157K | 309K | 457K | 0 | 161K | 313K | 460K | 178K | 302K | 424K | 577K | 851K | 967K | 6.73M | 1.1M | 6.03M | 5.97M |
| Long-Term Debt | 309K | 457K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 157K | 309K | 457K | 0 | 161K | 313K | 460K | 178K | 302K | 422K | 573K | 680K | 783K | 883K | 610K | 667K | 721K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 184K | 0 | 0 | 0 | 152K | 0 | 239K |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 4K | 171K | 184K | 5.85M | 336K | 5.36M | 5.01M |
| Total Liabilities | 6.76M | 7.47M | 5.92M | 6.16M | 7.2M | 9.97M | 10.61M | 12.21M | 14.75M | 14.2M | 11.91M | 13.72M | 15.94M | 16.09M | 13.4M | 13.15M | 17.41M | 6.08M | 11.35M | 10.21M |
| Total Debt | 871K | 1M | 599K | 737K | 870K | 1M | 576K | 692K | 801K | 906K | 644K | 749K | 849K | 945K | 1.04M | 1.12M | 1.21M | 808K | 857K | 903K |
| Net Debt | -106.33M | -70.89M | -43.82M | -24.56M | -27.53M | -12.88M | -20.45M | -8.46M | -17.61M | -1.62M | -3.33M | -13.06M | -23.05M | -16.18M | -20.31M | -25.86M | -13.04M | -20.65M | -25.42M | -29.01M |
| Debt / Equity | 0.01x | 0.01x | 0.01x | 0.03x | 0.03x | 0.11x | 0.04x | 0.24x | 0.08x | - | - | 0.15x | 0.06x | 0.19x | 0.08x | 0.06x | 0.30x | 0.04x | 0.03x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 107.41M | 70.87M | 45.63M | 26.15M | 27.76M | 9.46M | 15.89M | 2.91M | 9.68M | -7.98M | -3.83M | 4.84M | 13.17M | 4.85M | 12.6M | 19.06M | 4.03M | 20.35M | 26.61M | 33.41M |
| Equity Growth % | 286.94% | 648.77% | 187.13% | 797.67% | 186.65% | 218.67% | 515.26% | -39.85% | -26.46% | -264.42% | -130.38% | -74.59% | 227.18% | -76.16% | -52.66% | -42.97% | -86% | -27.23% | 234.76% | 783.29% |
| Book Value per Share | 0.62 | 0.46 | 0.42 | 0.27 | 0.32 | 0.13 | 0.23 | 0.05 | 0.22 | -0.26 | -0.13 | 0.17 | 0.56 | 0.23 | 0.61 | 0.94 | 0.25 | 1.28 | 1.68 | 2.19 |
| Total Shareholders' Equity | 107.41M | 70.87M | 45.63M | 26.15M | 27.76M | 9.46M | 15.89M | 2.91M | 9.68M | -7.98M | -3.83M | 4.84M | 13.17M | 4.85M | 12.6M | 19.06M | 4.03M | 20.35M | 26.61M | 33.41M |
| Common Stock | 18K | 15K | 12K | 10K | 9K | 7K | 6K | 5K | 5K | 3K | 3K | 3K | 3K | 2K | 2K | 2K | 2K | 2K | 2K | 2K |
| Retained Earnings | -283.39M | -274.99M | -267.33M | -260.54M | -253.94M | -248.13M | -241.39M | -234.28M | -226.81M | -217.24M | -209.11M | -199.84M | -191M | -179.9M | -170.78M | -163.76M | -155.35M | -138.6M | -132M | -124.92M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |